Author： Thompson Charis
Publisher： Future Medicine
ISSN： 1746-0751
Source： Regenerative Medicine, Vol.2, Iss.2, 2007-03, pp. : 203-209
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Why Should We Integrate Biomarkers into Complex Trials?
Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 19, Iss. 5, 2012-10 ,pp. :
Access to resources
Recommend
Why should we care if onychomycosis is truly onychomycosis?
BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 2, 2015-02 ,pp. :
Understanding Equivalence Trials (and Why We Should Care)
Canadian Journal of Emergency Medicine, Vol. 2, Iss. 3, 2000-07 ,pp. :
Underdetermination in science: What it is and why we should care
PHILOSOPHY COMPASS (ELECTRONIC), Vol. 13, Iss. 2, 2018-02 ,pp. :
NICE work: how NICE decides what we should pay for
British Journal of General Practice, Vol. 60, Iss. 570, 2010-01 ,pp. :